CopyFind
Rimodar Forte 37.5 mg/750 mg Tablet
药品 📍 IN

Rimodar Forte 37.5 mg/750 mg Tablet

4,81 ₹

Analogs of Rimodar Forte 37.5 mg/750 mg Tablet

Find cheaper analogs and generic equivalents for Rimodar Forte 37.5 mg/750 mg Tablet.

Ingredients

活性成分: Pyrimethamine; Sulphadoxine


产品概览

About Rimodar Forte

Rimodar Forte is a medication containing the active ingredient Pyrimethamine, classified as Dihydrofolate Reductase Inhibitor Antimalarial. Pyrimethamine, sold under the brand name Daraprim among others, is a medication used with leucovorin to treat the parasitic diseases toxoplasmosis and cystoisosporiasis. It is also used with dapsone as a second-line option to prevent Pneumocystis jiroveci pneumonia in people with HIV/AIDS.

Key Benefits & Uses

  • Used for: INDICATIONS AND USAGE Treatment of Toxoplasmosis : Pyrimethamine tablets are indicated for the treatment of toxoplasmosis when used conjointly with a.
  • Use only as directed on the product label or by a healthcare professional.
  • Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

Pyrimethamine, the active ingredient in Rimodar Forte, belongs to the Dihydrofolate Reductase Inhibitor Antimalarial class. INDICATIONS AND USAGE Treatment of Toxoplasmosis : Pyrimethamine tablets are indicated for the treatment of toxoplasmosis when used conjointly with a sulfonamide, since synergism exists with this combination. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Rimodar Forte. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Rimodar Forte for extended periods without medical advice.

Find in Pharmacies

Compare local prices and distance for Rimodar Forte 37.5 mg/750 mg Tablet.

Visitor ratings

Help others by rating how useful this product page is.

No ratings yet — be the first.